Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Dermatomycoses Market?

The dermatomycoses industry has witnessed a consistent expansion in its market size over the previous years and is expected to advance from $14.12 billion in 2024 to $14.81 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%. The significant growth during the past period can be linked to the progression in antifungal treatments, escalating occurrences of fungal infections, an uptick in consciousness about skin wellness, advancements in diagnostic methodologies, and the flourishing expansion of over-the-counter antifungal merchandise.

Anticipations are high for robust expansion in the dermatomycoses market in the coming years. By 2029, this market is projected to achieve a growth of 5.3% Compound Annual Growth Rate (CAGR), reaching a worth of $18.17 billion. Factors influencing this upward trend during the projected period include an aging population, a rise in drug-resistant fungal strains, amplified need for natural and organic antifungal items, enhanced developments in biotech and antifungal research, and the widening access to healthcare in emerging regions. Some of the prominent trends projected in this period include the creation of new antifungal medications, advancements in fast diagnostic methods, the implementation of artificial intelligence in dermatology, progress in nanotechnology, based antifungal treatments, and fresh innovations in microbiome-centered therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21934&type=smp

Which Industry Forces Are Driving The Dermatomycoses Market Forward?

The dermatomycoses market’s progression is anticipated to be driven by the rising occurrence of fungal infections. These medical conditions, caused by fungi, affect various parts of the body including skin, nails, hair, and internal organs, leading to an array of health problems. Overuse of broad-spectrum antibiotics can upset the natural microbiome, providing an environment where fungi can flourish and result in infections. This imbalance undermines the natural defense mechanisms of the human body, thereby increasing susceptibility to opportunistic fungal infections. Dermatomycoses, resulting from dermatophytes, yeasts, and molds, lead to a variety of superficial and systemic infections, affecting different tissues. For example, in November 2023, the UK Health Security Agency stated that global predictions reveal an annual count of 6.5 million invasive fungal infections, causing around 3.8 million deaths, and 2.5 million of those deaths can be directly linked to these infections. Hence, the escalating rate of fungal infections is propelling the dermatomycoses market’s growth.

How Is The Dermatomycoses Market Organized By Different Segments?

The dermatomycosesmarket covered in this report is segmented –

1) By Drugs: Corticosteroids; Corticosteroid-Sparing Agents; Immunosuppressive; Immunomodulator; Antifungals; Other Drugs

2) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration

3) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids

2) By Corticosteroid-Sparing Agents: Tacrolimus; Pimecrolimus

3) By Immunosuppressive: Methotrexate; Azathioprine; Cyclophosphamide

4) By Immunomodulator: Interferon-Gamma; Thalidomide

5) By Antifungals: Topical Antifungals; Oral Antifungals; Systemic Antifungals

6) By Other Drugs: Antihistamines; Antibacterial Agents

What Current And Upcoming Trends Are Shaping The Dermatomycoses Market?

In the dermatomycoses market, companies are focusing on investigational new drug (IND) candidates to advance onychomycosis treatment and boost efficacy. IND candidates are drugs in preclinical or clinical stages to assess safety and efficacy before approval. For example, in January 2024, Vanda Pharmaceuticals Inc., a US biopharmaceutical firm, received FDA approval for its IND candidate VTR-297 to treat onychomycosis. VTR-297 is a topical antifungal with histone deacetylase (HDAC) inhibitor properties, setting it apart from conventional antifungals. It targets fungal growth at its source and exhibits strong activity against dermatophytes and other fungi. This novel action may offer faster, more effective treatments and reduce recurrence rates, addressing unmet needs in onychomycosis therapy.

Who Are The Primary Market Leaders In The Dermatomycoses Market?

Major companies operating in the dermatomycoses market are Pfizer Inc., Bayer AG, Saphnix Life Sciences, MITS Healthcare Private Limited, Weefsel Pharma, AdvaCare Pharma, Associated Biotech, Healthy Life Pharma Private Limited, Blueberry Therapeutics Ltd., Livealth Biopharma Pvt. Ltd., LGM Pharma, SiNi Pharma Pvt. Ltd., Joshi Agrochem Pharma Private Limited, Wellona Pharma, Abiba Pharmacia Pvt. Ltd., Vee Excel Drugs & Pharmaceuticals Pvt. Ltd., Femcorp Pharma, Lexicare Pharma Pvt. Ltd., Glamris Dermacare, Henin Lukinz

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dermatomycoses-global-market-report

How Do Regional Dynamics Influence The Dermatomycoses Market Performance?

North America was the largest region in the dermatomycoses market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatomycoses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21934&type=smp

Browse Through More Reports Similar to the Global Dermatomycoses Market 2025, By The Business Research Company

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Pharmaceutical Drugs And Biologics Logistics Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-market

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model